Myeloma : subject feeds
Impact of the time interval between end of induction and autologous hematopoietic transplantation in newly diagnosed patients with multiple myeloma
Publisher Correction: Oncogenic RAS commandeers amino acid sensing machinery to aberrantly activate mTORC1 in multiple myeloma
Elevated SFXN2 limits mitochondrial autophagy and increases iron-mediated energy production to promote multiple myeloma cell proliferation
I-OPen: inferior outcomes of penta-refractory compared to penta-exposed multiple myeloma patients
Oncogenic RAS commandeers amino acid sensing machinery to aberrantly activate mTORC1 in multiple myeloma
Paraskeletal and extramedullary plasmacytomas in multiple myeloma at diagnosis and at first relapse: 50-years of experience from an academic institution
Ixazomib, lenalidomide and dexamethasone consolidation with randomized ixazomib or lenalidomide maintenance after autologous transplant in newly diagnosed multiple myeloma
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study
The prognostic value of the MASS in a multi-center cohort of patients with newly diagnosed multiple myeloma
CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignancies
High response rates with single-agent belantamab mafodotin in relapsed systemic AL amyloidosis
Comparison of two free light chain assays: performance of the involved free light chain ratio and implications for diagnosis of multiple myeloma
Efficacy of SARS-CoV-2 primary and booster vaccine doses in CAR-T recipients – targeting the target antigen
When an embarrassment of riches isn’t enough
Venetoclax ex vivo functional profiling predicts improved progression-free survival
The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states
Calorie restriction has no effect on bone marrow tumour burden in a Vk*MYC transplant model of multiple myeloma
Distribution of clonal hematopoiesis of indeterminate potential (CHIP) is not associated with race in patients with plasma cell neoplasms
Exploiting gene dependency to inform drug development for multiple myeloma
Immune senescence in multiple myeloma—a role for mitochondrial dysfunction£
The surfaceome of multiple myeloma cells suggests potential immunotherapeutic strategies and protein markers of drug resistance
Anthropometric traits and risk of multiple myeloma: a pooled prospective analysis
Paired miRNA- and messenger RNA-sequencing identifies novel miRNA-mRNA interactions in multiple myeloma
Overall survival as a primary end point in multiple myeloma trials
Clinician survey regarding measurable residual disease-guided decision-making in multiple myeloma
Blocking glycine utilization inhibits multiple myeloma progression by disrupting glutathione balance
The metabolic profile of reconstituting T-cells, NK-cells, and monocytes following autologous stem cell transplantation and its impact on outcome
FOXM1 regulates glycolysis and energy production in multiple myeloma
Differences in the cytogenetic underpinnings of AL amyloidosis among African Americans and Caucasian Americans
The genetic heterogeneity and drug resistance mechanisms of relapsed refractory multiple myeloma
Feed Fetched by RSS Dog.